ELV

Elevance Health Inc. Common Stock (ELV)

Stock · NYSE · Health Care

$394.43as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 29, 2026

Ruane, Cunniff & Goldfarb Adjust Position in Elevance Health in Q2 Update. A recent portfolio update noted that Ruane, Cunniff & Goldfarb, an established investment firm, adjusted its holdings in Elevance Health during the second quarter. The commentary tracked changes in the firm's portfolio rather than announcing a company-specific event for Elevance Health. The stock is currently trading above the midpoint of its 52-week range and below the average analyst price target, which may be useful context for understanding why portfolio activity in the name is being watched.

Active signals

Support level
$386.63
Industry
Medical Specialities

About ELV

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based a…

Sector
Health Care
Industry
Medical Specialities
Employees
96,129

Fundamentals

1-day range
$394.41$403.12
Market cap
$83.01B
P/E (trailing)
17.57
P/E (forward)
13.32
EPS (trailing)
$22.50
Dividend yield
1.24%
Beta
0.72
Avg. volume
1.44M
Ex-dividend date
September 10, 2026
Dividend pay date
September 25, 2026
52-week range
$274.84$436.24
Next earnings: October 21, 2026 · EPS estimate $4.66Before Openconfirmed

How Elevance Health Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$199.13BNet Income$5.66B (3%)Other$150.25B (75%)Cost of Revenue$21.18B (11%)SG&A$20.98B (11%)Tax$1.05B (1%)ELV

Source: 10-K filed Feb 6, 2026 · via SEC EDGAR / Finnhub

Forecasts

21 analyst ratings

Buy 66%
Hold 35%
Sell 0%
1-year price forecast
High
$492
+24.7%
Median
$457
+15.9%
Low
$393
-0.4%

Elevance Health Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ELV
    Elevance Health Inc. Common Stock
    $394.81
    ▼ 1.08%
    Market cap $83.01BP/E 17.57
    $274.84$436.24
  • CI
    The Cigna Group Common Stock
    $278.88
    ▲ 0.44%
    Market cap $74.53BP/E 11.52
    $239.51$315.47
  • NTRA
    Natera Inc. Common Stock
    $326.47
    ▼ 3.61%
    Market cap $38.72BP/E
    $157.43$343.18
  • CNC
    Centene Corporation Common Stock
    $64.77
    ▼ 0.86%
    Market cap $31.50BP/E
    $28.24$69.36
  • ILMN
    Illumina Inc. Common Stock
    $215.65
    ▼ 5.29%
    Market cap $29.98BP/E 34.73
    $88$231.81
  • GH
    Guardant Health Inc. Common Stock
    $161.76
    ▼ 4.01%
    Market cap $21.31BP/E
    $53.4$176.58
  • MOH
    Molina Healthcare Inc Common Stock
    $199.88
    ▲ 0.57%
    Market cap $10.17BP/E 1249.59
    $121.06$244.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
9.2K
Disposed
2.1K

Institutional Ownership

March 31, 2026

Total shares held
187.15M
Total value held
$51.71B
Institutional holders
1452
Top holders this quarter
  • Unknown19.89M
  • Unknown14.35M
  • Unknown10.29M
  • Unknown8.23M
  • Unknown5.89M
  • Unknown5.19M
  • Unknown5.14M
  • Unknown5.13M
  • Unknown4.82M
  • Unknown4.75M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.